On May 11, 2026, BIOX reported earnings of -0.16 USD per share (EPS) for Q3 26, missing the estimate of -0.05 USD, resulting in a -213.73% surprise. Revenue reached 38.20 million, compared to an expected 55.59 million, with a -31.28% difference. The market reacted with a +15.48% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.